跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXLANSOPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DEXLANSOPRAZOLE
Authorized
STANDARD
DEXLANSOPRAZOLE
altius healthcare inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3a263fd138414366
Company
altius healthcare inc
Type
Standard
Approval Details
Approval Id
3a263fd138414366
Drug Approval Canada Name
DEXLANSOPRAZOLE
Product Name
DEXLANSOPRAZOLE
Status
Cancelled Post Market
Status Date
2025-04-17
Original Market Date
2024-01-23
Din
02536390
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Nasogastric , Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC06 DEXLANSOPRAZOLE
Atc Name
a 02 bc 06
Aig Number
0152766001
Company Name
altius healthcare inc
Company Address
360 Rue Des Entrepreneurs, Montmagny, Quebec, Canada, G5V 4T1
Active Ingredients
DEXLANSOPRAZOLE
30 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3a263fd138414366
Type
Standard
Back to Health Canada Approvals